get glp 1 with medicaid Louisiana lawmakers are considering a bill that would expand access to GLP-1 drugs for obesity treatment, a move supporters say could improve health outcomes and reduce long-term costs. https://bit.ly/4usEGVI Medicaid now covers GLP-1s for

Description

Because compounded semaglutide may differ in purity and strength compared to FDA-approved medications, the risks can be even greater

Call me if: You're vomiting and can't keep water down You have severe pain at the injection site You see signs of infection (warmth, pus, spreading redness) You're having trouble breathing or showing signs of an allergic reaction You're so nauseous you can't eat for more than 24 hours You just feel really off, and something doesn't seem right Don't call me if: You have mild nausea (totally normal) You saw a drop of blood (also normal) You're tired on the first day (expected) You have a small bruise (happens sometimes) When in doubt, send a message through the patient portal or call

Unlike GLP-1 medications, its effects are not fast-acting and havent been studied long-term in large groups

Bydureon (AstraZeneca) is an extended release (ER) formulation of Exenatide that requires only once a week dosing

Tirzepatide's greater glucose-lowering effect compared to semaglutide means hypoglycemia risk may increase, especially if you are also taking sulfonylureas or insulin